| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 18th, 2005 | 27 | No |
Popular Name: LITHOCHOLIC ACID LITHOCHOLIC ACID
Find On: PubMed — Wikipedia — Google
CAS Number: 434-13-9
3alpha-Hydroxy-5beta-cholan-24-oic Acid
434-13-9; Lithocholic acid; Prestwick_88
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 5.16 | 10.35 | -46.75 | 1 | 3 | -1 | 60 | 375.573 | 4 | ↓ |
| Lo Low (pH 4.5-6) | 5.16 | 8.37 | -7.04 | 2 | 3 | 0 | 58 | 376.581 | 4 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Mp [°C] | 182 - 188 | Acros Organics |
| Purity | 95% | Fluorochem |
| Purity | 98% | Fluorochem |
| UniProt Database Links | AK1C1_HUMAN; AK1C2_HUMAN; CP3A4_HUMAN; CP3AA_MESAU; CP4AL_PIG; HDHA_ECO57; HDHA_ECOLI; NR1H4_BOVIN; NR1H4_HUMAN; NR1H4_MOUSE; NR1H4_RAT | ChEBI |
| PUBCHEM_PATENT_ID | EP0012640A1; EP0023375A1; EP0032578A1; EP0056781A2; EP0058000A2; EP0061687A1; EP0088637A2; EP0106863A1; EP0108399A2; EP0119040A1; EP0127535A2; EP0135782A2; EP0168119A1; EP0168229A2; EP0168229B1; EP0204456A1; EP0204456B1; EP0208519A2; EP0232788A1; EP023705 | IBM Patent Data |
| Patent Database Links | EP1698636; EP1886685; EP1946746; EP1970051; US2004171188; US2007265187; WO2007086651; WO2007096431; WO2007106049 | ChEBI |
| Target | FXR | Selleck Chemicals |
| Target | Others | Selleck Chemicals |
| Reactome Database Links | REACT_17008; REACT_21388; REACT_22234; REACT_22268; REACT_6770 | ChEBI |
| S phrase | S24/25: Avoid contact with skin and eyes. | Acros Organics |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| GPBAR-2-E | G-protein Coupled Bile Acid Receptor 1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 580 | 0.32 | Functional ≤ 10μM |
| NR1H4-2-E | Bile Acid Receptor FXR (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6700 | 0.27 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| NR1H4_HUMAN | Q96RI1 | Bile Acid Receptor FXR, Human | 6700 | 0.27 | Functional ≤ 10μM |
| GPBAR_HUMAN | Q8TDU6 | G-protein Coupled Bile Acid Receptor 1, Human | 5600 | 0.27 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Class A/1 (Rhodopsin-like receptors) | |
| Cytosolic sulfonation of small molecules | |
| Endogenous sterols | |
| G alpha (s) signalling events | |
| PPARA activates gene expression | |
| Recycling of bile acids and salts | |
| Synthesis of bile acids and bile salts | |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| Description | Species |
|---|---|
| Class A/1 (Rhodopsin-like receptors) | |
| Endogenous sterols | |
| G alpha (s) signalling events | |
| PPARA activates gene expression | |
| Recycling of bile acids and salts | |
| Synthesis of bile acids and bile salts | |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |